If you’ve ever wanted to join us for Spring Advocacy Day, but couldn’t make it to Capitol Hill, now is your chance! Every spring, we bring together survivors, caregivers and supporters in Washington, D.C., to advocate for issues important to the ovarian cancer community. It’s a rare opportunity to communicate directly with your Members of … Continued
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship. “Inspired Advice” is a blog series that tackles specific topics – from what you wish you knew when first diagnosed to what you need most from a life partner – and shares … Continued
Dr. Shannon Westin–Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine at UT MD Anderson Cancer Center, and Director of Early Drug Development/Phase I Trials–has a motto: Research is what cures cancer. Dr. Westin spoke at our International Gynecologic Cancer Conference, sharing everything from what exactly a clinical trial is and how it … Continued
Registration closes on December 17, 2021. Together, we made great strides in 2020 on Capitol Hill, and we are excited to announce that we now have more OCRA Advocate Leaders than ever before speaking up for the ovarian cancer community. With more than 120 individuals selected—including 53 returning participants—our Advocate Leader program has more than … Continued
OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D., first author, both at MD Anderson Cancer Center, along with colleagues, identified potential biomarkers in subgroups of high-grade serous ovarian cancer (HGSC). Biomarkers are unique biological indicators of an event, or the presence of a substance in the body. Biomarkers are useful … Continued
The rollout of COVID-19 vaccines in the United States has many feeling hopeful about the possibility of gaining some protection against the virus. But as with any new medical advancement, it is not uncommon for people to have questions about its safety and efficacy. And for those who are living with ovarian cancer, there are … Continued
Once a person has been treated for ovarian cancer, and all traces of the disease have been removed, there is rightful cause for celebration and relief. Still, the possibility of a recurrence is often in the back (or the front) of a patient’s mind. Dr. Stephanie Wethington, gynecologic oncologist at Johns Hopkins Medicine, joined us … Continued
A recent study, published in Cancer Research and reported in The New York Times, suggests that risk-reduction associated with oral contraceptive use can last a lifetime. The link between lower ovarian and endometrial cancer risk and oral contraceptive use has long been established; however, it was unclear how long after taking oral contraceptives a woman … Continued
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship. Inspired Advice is a blog series that tackles specific topics – from managing treatment-related nausea to tips for staying positive – and shares advice and reflections from our OCRA Inspire Online Community. … Continued
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship. Inspired Advice is a blog series that tackles specific topics – from intimacy post-diagnosis to tips for staying positive – and shares advice and reflections from our OCRA Inspire … Continued
“I don’t think of myself as a hero,” said Amy Hollub, ovarian cancer survivor who—along with the help of her family, close friends, and an advisory board—spearheaded a fundraising event in Miami. “It’s my whole community.” Indeed, the idea of community plays a big role in Amy’s ovarian cancer experience – from her own family … Continued
It’s hard to believe 2020 is almost over, and what a year it’s been. Despite the challenges wrought by the pandemic, we’re grateful to report that thanks to your support, OCRA grantees made great strides in ovarian cancer discoveries, bringing us ever closer to improving care and defeating this devastating disease: Revealed two cells of origin for high-grade serous ovarian cancer — … Continued
Get email updates about research news, action alerts, and ways to join the fight.
